A stilbenol that is stilbene in which the phenyl groups are substituted at positions 3, 5, and 4' by hydroxy groups.
Chemical ID:
MESH:C059514
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol inhibits the reaction [Cadmium Chloride results in decreased expression of BCL2 protein]]; 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [Resveratrol inhibits the reaction [Cadmium Chloride results in decreased expression of BCL2 protein]]; 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [Resveratrol results in increased expression of BCL2 protein]; [1-Methyl-4-phenylpyridinium co-treated with Resveratrol] results in increased expression of BCL2 mRNA; [MRS 1191 results in decreased activity of ADORA3 protein] inhibits the reaction [Resveratrol results in increased phosphorylation of BCL2 protein]; [Resveratrol co-treated with Propofol] results in increased expression of BCL2; Chloroquine inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in decreased expression of BCL2 protein]]; dorsomorphin inhibits the reaction [Resveratrol inhibits the reaction [Cadmium Chloride results in decreased expression of BCL2 protein]]; dorsomorphin inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in decreased expression of BCL2 protein]]; Resveratrol inhibits the reaction [Cadmium Chloride results in decreased expression of BCL2 mRNA]; Resveratrol inhibits the reaction [Cadmium Chloride results in decreased expression of BCL2 protein]; Resveratrol inhibits the reaction [chromium hexavalent ion results in decreased expression of BCL2 protein]; Resveratrol inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein]; Resveratrol inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2 protein]; Resveratrol inhibits the reaction [Gallic Acid results in decreased expression of BCL2 protein]; Resveratrol inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; Resveratrol inhibits the reaction [MIR136 promotes the reaction [Paraquat results in decreased expression of BCL2 protein]]; Resveratrol inhibits the reaction [Monocrotophos results in decreased expression of BCL2 mRNA]; Resveratrol inhibits the reaction [Monocrotophos results in decreased expression of BCL2 protein]; Resveratrol inhibits the reaction [Oxygen results in increased expression of BCL2 protein]; Resveratrol inhibits the reaction [Paraquat results in decreased expression of BCL2 protein]; Resveratrol inhibits the reaction [Testosterone results in increased expression of BCL2 protein]
[Resveratrol results in decreased expression of MTA1 protein] which results in decreased expression of BCL2 protein; Resveratrol analog results in decreased expression of BCL2 protein; Resveratrol results in decreased expression of BCL2; Resveratrol results in decreased expression of BCL2 mRNA; Resveratrol results in decreased expression of BCL2 protein
[Ellagic Acid co-treated with Resveratrol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 mRNA]; [Plant Extracts co-treated with Resveratrol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 mRNA]; Resveratrol affects the reaction [Doxorubicin results in decreased expression of BCL2 protein]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 protein]; Resveratrol inhibits the reaction [Arginine results in increased expression of BCL2 mRNA]; Resveratrol inhibits the reaction [Arginine results in increased expression of BCL2 protein]; Resveratrol inhibits the reaction [Ceruletide results in increased expression of BCL2 mRNA]; Resveratrol inhibits the reaction [Ceruletide results in increased expression of BCL2 protein]; Resveratrol inhibits the reaction [Dietary Fats results in decreased expression of BCL2 mRNA]; Resveratrol inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]; Resveratrol inhibits the reaction [ERCC6 gene mutant form results in decreased expression of BCL2 protein]; Resveratrol inhibits the reaction [glyoxylic acid results in decreased expression of BCL2 protein]; zinc protoporphyrin inhibits the reaction [Resveratrol inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]]
[allyl sulfide co-treated with Resveratrol] results in decreased expression of BCL2 mRNA; [Benzo(a)pyrene co-treated with Resveratrol] results in decreased expression of BCL2 mRNA; [Doxorubicin co-treated with Resveratrol] results in decreased expression of BCL2 mRNA; [Doxorubicin co-treated with Resveratrol] results in decreased expression of BCL2 protein; [Resveratrol co-treated with beta-1,3-glucan] results in increased expression of BCL2 mRNA; [Resveratrol co-treated with Glucose] results in increased expression of BCL2 protein; [Resveratrol co-treated with Raloxifene Hydrochloride] results in decreased expression of BCL2 mRNA; Acetylcysteine inhibits the reaction [Arsenic Trioxide promotes the reaction [Resveratrol results in decreased expression of BCL2 protein]]; Acetylcysteine inhibits the reaction [Resveratrol promotes the reaction [Arsenic Trioxide results in decreased expression of BCL2 protein]]; Acetylcysteine inhibits the reaction [Resveratrol results in decreased expression of BCL2 protein]; Arsenic Trioxide promotes the reaction [Resveratrol results in decreased expression of BCL2 protein]; BCL2 protein inhibits the reaction [Resveratrol affects the localization of CYCS protein]; BCL2 protein inhibits the reaction [Resveratrol promotes the reaction [[CASP3 protein results in increased cleavage of aspartyl-glutamyl-valyl-aspartyl-p-nitroanilide] which results in increased chemical synthesis of 4-nitroaniline]]; BCL2 protein inhibits the reaction [Resveratrol promotes the reaction [PML protein binds to CREBBP protein]]; BCL2 protein inhibits the reaction [Resveratrol promotes the reaction [PML protein binds to DAXX protein]]; BCL2 protein inhibits the reaction [Resveratrol promotes the reaction [PML protein binds to SP100 protein]]; BCL2 protein inhibits the reaction [Resveratrol promotes the reaction [PML protein binds to SUMO1 protein]]; BCL2 protein inhibits the reaction [Resveratrol promotes the reaction [PML protein binds to TP53 protein]]; BCL2 protein inhibits the reaction [Resveratrol results in decreased expression of BIRC2 protein]; BCL2 protein inhibits the reaction [Resveratrol results in decreased expression of BIRC3 protein]; BCL2 protein inhibits the reaction [Resveratrol results in decreased expression of CASP3 protein]; BCL2 protein inhibits the reaction [Resveratrol results in increased activity of CASP3 protein]; BCL2 protein inhibits the reaction [Resveratrol results in increased cleavage of and results in increased activity of CASP3 protein]; BCL2 protein inhibits the reaction [Resveratrol results in increased cleavage of PARP1 protein]; BCL2 protein inhibits the reaction [Resveratrol results in increased cleavage of PLCG1 protein]; BCL2 protein inhibits the reaction [Resveratrol results in increased degradation of PLCG1 protein]; chelerythrine inhibits the reaction [Resveratrol affects the expression of BCL2 protein]; diphenyleneiodonium inhibits the reaction [Resveratrol affects the expression of BCL2 protein]; MIR21 mRNA inhibits the reaction [Resveratrol results in decreased expression of BCL2 protein]; NQO2 protein promotes the reaction [Resveratrol results in decreased expression of BCL2 protein]; pyrrolidine dithiocarbamic acid inhibits the reaction [Resveratrol results in increased expression of BCL2 mRNA]; Resveratrol inhibits the reaction [[Arachidonic Acid co-treated with Iron] results in decreased expression of BCL2 protein]; Resveratrol inhibits the reaction [[Oxygen co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]; Resveratrol inhibits the reaction [cudraflavone B results in decreased expression of BCL2 protein]; Resveratrol inhibits the reaction [Dopamine results in decreased expression of BCL2 protein]; Resveratrol inhibits the reaction [MIR21 mRNA results in increased expression of BCL2 protein]; Resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of BCL2 mRNA]; Resveratrol inhibits the reaction [Paclitaxel results in increased phosphorylation of BCL2 protein]; Resveratrol inhibits the reaction [Rotenone results in decreased expression of BCL2 mRNA]; Resveratrol inhibits the reaction [Rotenone results in decreased expression of BCL2 protein]; Resveratrol promotes the reaction [Arsenic Trioxide results in decreased expression of BCL2 protein]; Resveratrol promotes the reaction [Sorafenib results in decreased expression of BCL2 protein]; Resveratrol promotes the reaction [Temozolomide results in decreased expression of BCL2 protein]; Vorinostat inhibits the reaction [BCL2 protein inhibits the reaction [Resveratrol results in increased cleavage of and results in increased activity of CASP3 protein]]; Vorinostat inhibits the reaction [BCL2 protein inhibits the reaction [Resveratrol results in increased cleavage of PARP1 protein]]; Vorinostat inhibits the reaction [BCL2 protein results in decreased susceptibility to Resveratrol]
